Related Experiment Video
Updated: Jun 25, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Combating HIV resistance - focus on darunavir.
1Department of Microbiology and Immunology, Centre Hospitalier de l'Université de Montréal, Montréal, Canada. c.tremblay@umontreal.ca
Therapeutics and Clinical Risk Management
|February 12, 2009
Summary
Darunavir, a protease inhibitor, effectively suppresses HIV-1 in treatment-experienced individuals. It offers potent antiviral efficacy and a high genetic barrier, preserving future treatment options.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Darunavir is a second-generation protease inhibitor developed for HIV-1 strains with multiple resistance mutations.
- Pivotal trials show darunavir significantly enhances virological suppression in treatment-experienced individuals when added to optimized background treatment.
Purpose of the Study:
- To evaluate the efficacy and resistance profile of darunavir in treatment-experienced HIV-1 infected individuals.
- To compare darunavir's virological suppression and CD4 count increase against control protease inhibitors.
Main Methods:
- Clinical trials involving treatment-experienced HIV-1 infected individuals.
- Analysis of virological suppression, CD4 counts, and resistance-associated mutations.
- Assessment of baseline darunavir susceptibility as a predictor of response.
Main Results:
- Darunavir addition led to greater virological suppression and sustained CD4 count increases compared to control protease inhibitors.
- Defined darunavir resistance mutations include V11I, V32I, L33F, I47V, I50V, I54L/M, G73S, L76V, I84V, and L89V.
- Baseline susceptibility strongly predicted virological response; prior fosamprenavir use was linked to darunavir resistance mutations.
Conclusions:
- Darunavir demonstrates potent virological efficacy and a high genetic barrier, preserving treatment options for experienced HIV patients.
- Distinct resistance patterns observed with darunavir compared to other protease inhibitors like tipranavir.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...